1 |
ANDERSON, S. AND HAUCK, W. W. (1990). 'Consideration of individual bioequivalence', Journal of Pharmacokinetics and Biopharmaceutics, 18, 259-273
DOI
|
2 |
CHEN, M. L. (1997). 'Individual bioequivalence-a regulatory update', Journal of Biopharmaceutical Statistics, 7, 5-11
DOI
ScienceOn
|
3 |
CHOW, S-C. AND LIU, J-P. (2000). Design and Analysis of Bioavailability and Bioequivalence Studies, 2nd ed., Marcel Dekker, New York
|
4 |
FDA DRAFT GUIDANCE (1997). Draft guidance on in vivo bioequivalence studies based on population and individual bioequivalence approaches, Division of bioequivalence, office of generic drugs, center for drug evaluation and research, U.S. Food and Drug Administration, Maryland
|
5 |
HAUCK, W. W., BOIS, F. Y., HYSLOP, T., GEE, L. AND ANDERSON, S. (1997). 'A parametric approach to population bioequivalence', Statistics in Medicine, 16, 441-454
DOI
ScienceOn
|
6 |
PATNAIK, R. N., LESKO, L. J., CHEN, M. L., WILLIAMS, R. L. AND THE FDA POPULATION AND INDIVIDUAL BIOEQUIVALENCE WORKING GROUP (1997). 'Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics', Clinical Pharmacokinetics, 33, 1-6
|
7 |
SCHALL, R. (1995). 'Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar', Biometrics, 51, 615-626
DOI
ScienceOn
|
8 |
GRIEVE, A. P. (1985). 'A Bayesian analysis of the two-period crossover design for clinical trials', Biometrics, 41, 979-990
DOI
ScienceOn
|
9 |
LIU, J -P. AND CHOW, S-C. (1992). 'On the assessment of variability in bioavailability/bioequivalence studies', Communications in Statistics-Theory and Methods, 21, 2591-2607
DOI
|
10 |
WANG, W. (1997). 'Optimal unbiased tests for equivalence in intrasubject variability', Journal of the American Statistical Association, 92, 1163-1170
DOI
|
11 |
OH, H. S., Ko, S-G. AND OH, M-S. (2003). 'A Bayesian approach to assessing population bioequivalence in a 2 2 crossover design', Journal of Applied Statistics, 30, 881-891
DOI
ScienceOn
|
12 |
LIU, J-P. (1991), 'Bioequivalence and intrasubject variability', Journal of Biopharmaceutical Statistics, 1, 205-219
DOI
ScienceOn
|
13 |
CHEN, K-W., LI, G., SUN, Y. AND CHOW, S-C. (1996). 'A confidence region approach for assessing equivalence in variability of bioavailability', Biometrical Journal, 38, 475-487
DOI
ScienceOn
|
14 |
BERGER, J. O. (1985). Statistical Decision Theory and Bayesian Analysis, Springer-Verlag, New York
|
15 |
HASTINGS, W. K. (1970). 'Monte Carlo sampling methods using Markov chains and their applications', Biometrika, 57, 97-109
DOI
ScienceOn
|
16 |
HILLS, M. AND ARMITAGE, P. (1979). 'The two-period cross-over clinical trial', British Journal of Clinical Pharmacology, 8, 7-20
DOI
|